Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

休市中 05-17 16:00:00 EDT

0.7500

-0.0199

-2.58%

盘后0.7501

+0.0001+0.01%

18:56 EDT

最高0.7689	最低0.7388	成交量60.23万
今开0.7527	昨收0.7699	日振幅3.91%
总市值3,086万	流通市值1,190万	总股本4,115万
成交额45.42万	换手率3.80%	流通股本1,586万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.75,"timestamp":1715976000000,"preClose":0.7699,"halted":0,"volume":602302,"hourTrading":{"tag":"盘后","latestPrice":0.7501,"preClose":0.75,"latestTime":"18:56 EDT","volume":586,"amount":439.6248,"timestamp":1715986597861},"delay":0,"floatShares":15864609,"shares":41152616,"eps":-1.145647,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0199,"latestTime":"05-17 16:00:00 EDT","open":0.7527,"high":0.7689,"low":0.7388,"amount":454223.82478260004,"amplitude":0.039096,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.145647,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.7699,"preHourTrading":{"tag":"盘前","latestPrice":0.7694,"preClose":0.7699,"latestTime":"09:28 EDT","volume":2139,"amount":1638.931746,"timestamp":1715952522869},"postHourTrading":{"tag":"盘后","latestPrice":0.7501,"preClose":0.75,"latestTime":"18:56 EDT","volume":586,"amount":439.6248,"timestamp":1715986597861},"volumeRatio":1.194956127632651},"requestUrl":"/m/hq/s/SPRB/tweets","defaultTab":"tweets","newsList":[{"id":"2435300928","title":"斯普鲁斯生物科学公司（Spruce Biosciences Inc）报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435300928","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435300928?lang=zh_cn&edition=full","pubTime":"2024-05-14 04:46","pubTimestamp":1715633169,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc   报告了截至1月底的季度调整后每股亏损28美分，高于去年同期的每股-40美分。七位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-34美分至-19美分。* 营收同比增长 1.9%，达到 200 万美元；分析师预期为 116 万美元。* Spruce Biosciences Inc 公布的本季度每股收益为亏损 28 美分。* Spruce Biosciences Inc 本季度股价上涨了 6.0%，今年迄今为止亏损了 71.6%。* 生物技术和医学研究同行的平均一致建议也是 \"持有\"。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434865774","title":"Spruce Biosciences Inc   预计每股亏损29美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434865774","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434865774?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:58","pubTimestamp":1715356720,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc    预计将在5月13日公布截至2024年3月31日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司预计营收将从去年同期的196万美元下降41.0%，至115.8万美元。* LSEG 分析师对 Spruce Biosciences Inc 的平均预期是每股亏损 29 美分。* 华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于其最新收盘价 0.84 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434851351","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.77%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434851351","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434851351?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:36","pubTimestamp":1715348169,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时36分，Spruce Biosciences, Inc.股票出现异动，股价急速跳水5.77%。截至发稿，该股报0.790美元/股，成交量3.3896万股，换手率0.08%，振幅1.81%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213609861ec6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213609861ec6db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434770654","title":"Spruce Biosciences, Inc.盘中异动 急速拉升5.07%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434770654","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434770654?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:15","pubTimestamp":1715195745,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日03时15分，Spruce Biosciences, Inc.股票出现波动，股价快速拉升5.07%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nanoviricides, Inc.、Vigil Neuroscience, Inc.涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为254.48%、123.94%、41.53%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Geovax Labs Inc C/Wts 29/09/2025、Cel-Sci Corporation，振幅分别为80.33%、60.74%、58.08%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090315467a58c7e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090315467a58c7e5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432509048","title":"Spruce Biosciences, Inc.盘中异动 早盘急速上涨5.23%报0.745美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432509048","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432509048?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:46","pubTimestamp":1714574767,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时46分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨5.23%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Brainstorm Cell Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1225.75%、155.48%、37.41%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Palisade Bio, Inc.，振幅分别为188.34%、66.20%、32.84%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501224607861ea8b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501224607861ea8b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429311590","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429311590","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429311590?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:17","pubTimestamp":1713881840,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时17分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨5.27%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Palisade Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2150.26%、170.92%、32.56%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Palisade Bio, Inc.、Immunitybio, Inc.，振幅分别为35.00%、32.86%、27.32%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232217217922b2c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232217217922b2c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427600441","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.26%报0.698美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427600441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427600441?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:15","pubTimestamp":1713190559,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时15分，Spruce Biosciences, Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报0.698美元/股，成交量30.9905万股，换手率0.75%，振幅5.69%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152215597a52dccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152215597a52dccc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425343313","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.01%报0.865美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425343313","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425343313?lang=zh_cn&edition=full","pubTime":"2024-04-05 01:26","pubTimestamp":1712251610,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日01时26分，Spruce Biosciences, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报0.865美元/股，成交量61.089万股，换手率1.48%，振幅7.50%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405012650861e3722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405012650861e3722&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422187945","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.27%报0.737美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422187945","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422187945?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:59","pubTimestamp":1711558789,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时59分，Spruce Biosciences, Inc.股票出现波动，股价急速拉升5.27%。截至发稿，该股报0.737美元/股，成交量91.9074万股，换手率2.23%，振幅5.71%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280059497a4f8e5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280059497a4f8e5c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421814192","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.03%报0.718美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421814192","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421814192?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:00","pubTimestamp":1711116032,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时00分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.03%。截至发稿，该股报0.718美元/股，成交量33.4176万股，换手率0.81%，振幅4.82%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222200327a4e8ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222200327a4e8ad2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420728524","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌5.01%报0.711美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420728524","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420728524?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:47","pubTimestamp":1710942442,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时47分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.01%。截至发稿，该股报0.711美元/股，成交量34.3821万股，换手率0.84%，振幅7.62%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320214723861dfc2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320214723861dfc2b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420220922","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大跌6.10%报0.713美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420220922","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420220922?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:34","pubTimestamp":1710855264,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时34分，Spruce Biosciences, Inc.股票出现异动，股价快速下挫6.10%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为527.64%、148.43%、120.44%，振幅较大的相关个股有Enveric Biosciences, Inc.、Immuneering Corporation、Lantern Pharma Inc.，振幅分别为23.64%、17.58%、17.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921342587e7a0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921342587e7a0f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420650470","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅下跌5.02%报0.767美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420650470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420650470?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:47","pubTimestamp":1710769644,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时47分，Spruce Biosciences, Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报0.767美元/股，成交量55.3843万股，换手率1.35%，振幅7.70%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182147257a4d6fcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182147257a4d6fcb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419897127","title":"Spruce Biosciences, Inc.盘中异动 早盘急速上涨5.17%报0.853美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419897127","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419897127?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:31","pubTimestamp":1710509500,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时31分，Spruce Biosciences, Inc.股票出现波动，股价急速拉升5.17%。截至发稿，该股报0.853美元/股，成交量94.1068万股，换手率2.29%，振幅2.50%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152131417a4d13e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152131417a4d13e5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419805963","title":"Spruce Biosciences暴跌超84%，针对先天性肾上腺增生症的Cahmelia-203研究结果未能达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2419805963","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2419805963?lang=zh_cn&edition=full","pubTime":"2024-03-15 06:37","pubTimestamp":1710455820,"startTime":"0","endTime":"0","summary":"生物制药公司Spruce Biosciences Inc.（SPRB.US）收跌超84%，报0.811美元，总市值3300万美元。消息上，近日该公司宣布，针对先天性肾上腺增生症的Cahmelia-203研究结果未能达到主要终点。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-15/doc-inaniwra7161292.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-03-15/doc-inaniwra7161292.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419289607","title":"Spruce Biosciences, Inc.股价重挫76.69% 市值跌3806.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419289607","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419289607?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:31","pubTimestamp":1710423106,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时31分，Spruce Biosciences, Inc.股票出现波动，股价大幅跳水76.69%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、知临集团、Nuvectis Pharma, Inc.涨幅较大，Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃，换手率分别为115.85%、60.00%、58.29%，振幅较大的相关个股有知临集团、Renovorx, Inc.、Codexis, Inc.，振幅分别为16.17%、14.40%、8.58%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131468781e9e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131468781e9e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419166670","title":"斯普鲁斯生物科学公司（Spruce Biosciences Inc）报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2419166670","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419166670?lang=zh_cn&edition=full","pubTime":"2024-03-14 20:00","pubTimestamp":1710417613,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc   报告，截至12月底的季度调整后每股亏损24美分，高于去年同期的每股-47美分。七位分析师对该季度的平均预期是每股亏损 39 美分。华尔街预期为每股-50美分至-32美分。* 营收为 289 万美元，分析师预期为 140 万美元。* Spruce Biosciences Inc报告的本季度每股收益为亏损24美分。* Spruce Biosciences Inc 的股价本季度上涨了 77.1%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419467440","title":"BUZZ-斯普鲁斯生物公司因遗传性疾病治疗中期研究失败而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2419467440","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419467440?lang=zh_cn&edition=full","pubTime":"2024-03-14 19:16","pubTimestamp":1710415001,"startTime":"0","endTime":"0","summary":"** 该公司周三晚些时候称， ，其实验性疗法tildacerfont在一项针对成人典型先天性肾上腺皮质增生症的中期研究中没有达到主要目标** SPRB打算 ，以实施成本节约措施，包括终止研究和裁员约21%。** CAH 是一种罕见的遗传病，会影响人体产生和调节关键激素的能力。** 这一消息对 tildacerfont 在 CAH 领域的前景是一个重大打击，将带来时间安排和竞争风险--经纪商 RBC** 截至上日收盘，股价累计上涨 77.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"1179240510","title":"Spruce Biosciences Inc盘后暴跌75%！新药研究结果未能达到预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1179240510","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1179240510?lang=zh_cn&edition=full","pubTime":"2024-03-14 06:08","pubTimestamp":1710367681,"startTime":"0","endTime":"0","summary":"3月14日，生物制药公司$Spruce Biosciences Inc(SPRB)$美股盘后暴跌75%，该公司宣布，针对先天性肾上腺增生症的Cahmelia-203研究结果未能达到主要终点。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0993},{"period":"1month","weight":0.062},{"period":"3month","weight":-0.8506},{"period":"6month","weight":-0.4444},{"period":"1year","weight":-0.6681},{"period":"ytd","weight":-0.744}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.33989},{"month":2,"riseRate":0.5,"avgChangeRate":0.009378},{"month":3,"riseRate":0,"avgChangeRate":-0.297383},{"month":4,"riseRate":0,"avgChangeRate":-0.078867},{"month":5,"riseRate":0.5,"avgChangeRate":-0.00062},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.068831},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.022894},{"month":8,"riseRate":0.333333,"avgChangeRate":0.005525},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.195471},{"month":10,"riseRate":0,"avgChangeRate":-0.297781},{"month":11,"riseRate":0.5,"avgChangeRate":0.017474},{"month":12,"riseRate":0.5,"avgChangeRate":0.416923}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况